Advertisement
Australia markets closed
  • ALL ORDS

    7,937.50
    -0.40 (-0.01%)
     
  • ASX 200

    7,683.00
    -0.50 (-0.01%)
     
  • AUD/USD

    0.6496
    -0.0004 (-0.07%)
     
  • OIL

    82.84
    +0.03 (+0.04%)
     
  • GOLD

    2,341.10
    +2.70 (+0.12%)
     
  • Bitcoin AUD

    97,673.16
    -4,628.73 (-4.52%)
     
  • CMC Crypto 200

    1,359.16
    -23.41 (-1.69%)
     
  • AUD/EUR

    0.6074
    +0.0004 (+0.07%)
     
  • AUD/NZD

    1.0956
    +0.0014 (+0.13%)
     
  • NZX 50

    11,946.43
    +143.15 (+1.21%)
     
  • NASDAQ

    17,526.80
    +55.33 (+0.32%)
     
  • FTSE

    8,077.06
    +36.68 (+0.46%)
     
  • Dow Jones

    38,460.92
    -42.77 (-0.11%)
     
  • DAX

    17,931.30
    -157.40 (-0.87%)
     
  • Hang Seng

    17,284.54
    +83.27 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     

Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond

Got $1,000? 2 Stocks That Could Be Bargain Buys For 2022 and Beyond

Let's look at two biotech stocks that look attractive at current levels: AbbVie (NYSE: ABBV) and Gilead Sciences (NASDAQ: GILD). AbbVie is one of the largest pharmaceutical companies around. Like other drugmakers, AbbVie benefits from the fact that doctors do not stop prescribing lifesaving drugs even during challenging economic times, nor do patients stop taking them.